Published in J Virol on April 01, 1995
Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev (2001) 2.06
Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses. J Virol (1996) 1.97
Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J Virol (2005) 1.57
Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains. J Virol (1997) 1.44
Substitution of a single amino acid residue is sufficient to allow the human amphotropic murine leukemia virus receptor to also function as a gibbon ape leukemia virus receptor. J Virol (1996) 1.41
Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J Virol (1997) 1.41
Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol (1996) 1.26
Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J Virol (1996) 1.21
Mapping of the minimal inorganic phosphate transporting unit of human PiT2 suggests a structure universal to PiT-related proteins from all kingdoms of life. BMC Biochem (2011) 1.18
Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2. J Virol (2001) 1.18
Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins. J Virol (2002) 1.16
The amphotropic murine leukemia virus receptor gene encodes a 71-kilodalton protein that is induced by phosphate depletion. J Virol (1997) 1.13
Fungal phosphate transporter serves as a receptor backbone for gibbon ape leukemia virus. J Virol (1997) 1.08
Mutational analysis of the proposed gibbon ape leukemia virus binding site in Pit1 suggests that other regions are important for infection. J Virol (1997) 1.06
Reassessing the role of region A in Pit1-mediated viral entry. J Virol (2002) 1.03
Entry of amphotropic murine leukemia virus is influenced by residues in the putative second extracellular domain of its receptor, Pit2. J Virol (1998) 1.02
A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors. J Virol (2000) 1.01
Gibbon ape leukemia virus receptor functions of type III phosphate transporters from CHOK1 cells are disrupted by two distinct mechanisms. J Virol (1999) 1.00
Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses. Retrovirology (2005) 0.98
Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor. J Virol (2001) 0.96
Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1. J Virol (1998) 0.94
Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses. J Virol (2001) 0.93
Amphotropic murine leukemia virus entry is determined by specific combinations of residues from receptor loops 2 and 4. J Virol (1999) 0.92
Identification of an extracellular domain within the human PiT2 receptor that is required for amphotropic murine leukemia virus binding. J Virol (2004) 0.91
Regulation of cell proliferation and cell density by the inorganic phosphate transporter PiT1. Cell Div (2012) 0.88
Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections. J Virol (2007) 0.86
Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection. J Virol (2002) 0.83
A 13-amino-acid Pit1-specific loop 4 sequence confers feline leukemia virus subgroup B receptor function upon Pit2. J Virol (2000) 0.82
Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1. Sci Rep (2016) 0.79
Identification of two distinct structural regions in a human porcine endogenous retrovirus receptor, HuPAR2, contributing to function for viral entry. Retrovirology (2009) 0.79
Endogenous Gibbon Ape Leukemia Virus Identified in a Rodent (Melomys burtoni subsp.) from Wallacea (Indonesia). J Virol (2016) 0.78
Dissection of gammaretroviral receptor function by using type III phosphate transporters as models. J Virol (2005) 0.77
The central half of Pit2 is not required for its function as a retroviral receptor. J Virol (2004) 0.77
Primary Brain Calcification Causal PiT2 Transport-Knockout Variants can Exert Dominant Negative Effects on Wild-Type PiT2 Transport Function in Mammalian Cells. J Mol Neurosci (2016) 0.75
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
Improved retroviral vectors for gene transfer and expression. Biotechniques (1989) 19.48
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1987) 7.91
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol (1991) 6.19
A common progenitor for neurons and glia persists in rat retina late in development. Nature (1987) 5.54
Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A (1994) 4.67
Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Differ (1990) 4.50
Receptor interference groups of 20 retroviruses plating on human cells. Virology (1990) 4.15
Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A (1994) 4.07
A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci U S A (1994) 3.42
Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J Virol (1992) 2.80
Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions. J Virol (1991) 2.55
GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. J Virol (1992) 2.37
Definition of a domain of GLVR1 which is necessary for infection by gibbon ape leukemia virus and which is highly polymorphic between species. J Virol (1993) 1.99
Factors affecting retroviral vector function and structural integrity. Virology (1993) 1.59
Comparison of cDNAs encoding the gibbon ape leukaemia virus receptor from susceptible and non-susceptible murine cells. J Gen Virol (1994) 1.56
Gibbon ape leukemia virus and the amphotropic murine leukemia virus 4070A exhibit an unusual interference pattern on E36 Chinese hamster cells. J Virol (1993) 1.35
Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Differ (1990) 4.50
A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci U S A (1994) 3.42
Origin of the human L1 elements: proposed progenitor genes deduced from a consensus DNA sequence. Genomics (1987) 3.21
Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J Virol (1992) 2.80
GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. J Virol (1992) 2.37
A micromethod for detailed characterization of high molecular weight RNA. Methods Enzymol (1980) 2.36
Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J Virol (1993) 2.22
Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04
Definition of a domain of GLVR1 which is necessary for infection by gibbon ape leukemia virus and which is highly polymorphic between species. J Virol (1993) 1.99
Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour. Nature (1981) 1.97
SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J Virol (1991) 1.92
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci U S A (1978) 1.86
Evolutionarily conserved function of a viral microRNA. J Virol (2008) 1.81
A nucleotide substitution in the gag N terminus of the endogenous ecotropic DBA/2 virus prevents Pr65gag myristylation and virus replication. J Virol (1988) 1.72
Analysis of the genome of an endogenous, ecotropic retrovirus of the AKR strain of mice: micromethod for detailed characterization of high-molecular-weight RNA. J Virol (1980) 1.69
The nucleotide sequence of the Akv murine leukemia virus genome. Virology (1984) 1.51
Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J Virol (1993) 1.50
Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation. J Virol (1992) 1.37
Localization of the human gene allowing infection by gibbon ape leukemia virus to human chromosome region 2q11-q14 and to the homologous region on mouse chromosome 2. J Virol (1991) 1.37
Most sequence differences between the genomes of the Akv virus and a leukemogenic Gross A virus passaged in vitro are located near the 3' terminus. Proc Natl Acad Sci U S A (1980) 1.36
Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene. J Virol (2000) 1.30
Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J Gen Virol (1984) 1.29
Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses. J Virol (1989) 1.25
Analysis of the relA gene product of Escherichia coli. Eur J Biochem (1977) 1.22
Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene (1993) 1.20
Graduated resistance to G418 leads to differential selection of cultured mammalian cells expressing the neo gene. Gene (1989) 1.18
Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol Cell Biol (1992) 1.16
Characterization of virus produced by a lymphoma induced by inoculation of AKR MCF-247 virus. J Virol (1980) 1.16
Localization of functional domains in E. coli K-12 outer membrane porins. EMBO J (1985) 1.15
Increased cloning efficiency by temperature-cycle ligation. Nucleic Acids Res (1996) 1.14
Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3. J Virol (1996) 1.12
Structure of retroviral RNAs produced by cell lines derived from spontaneous lymphomas of AKR mice. J Virol (1982) 1.12
A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors. J Virol (1996) 1.10
Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and genomic characterization. Virology (1986) 1.09
Fungal phosphate transporter serves as a receptor backbone for gibbon ape leukemia virus. J Virol (1997) 1.08
Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site. J Virol (1997) 1.07
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo. J Virol (1997) 1.06
Isolation of a lambda transducing bacteriophage carrying the relA gene of Escherichia coli. J Bacteriol (1976) 1.05
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum Gene Ther (1998) 1.04
B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer. J Virol (1998) 1.04
Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences. J Virol (1990) 1.04
Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J Virol (2000) 1.03
Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin. J Virol (1999) 1.03
Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus. Virology (2005) 1.03
Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol (1997) 1.03
Crystal structure of AmiC: the controller of transcription antitermination in the amidase operon of Pseudomonas aeruginosa. EMBO J (1994) 1.03
Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region. J Virol (1998) 1.01
Genetic reassortment and patch repair by recombination in retroviruses. J Biomed Sci (2000) 1.00
Efficient non-PCR-mediated overlap extension of PCR fragments by exonuclease "end polishing". Biotechniques (1997) 0.97
Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression. Virology (1990) 0.97
Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo. J Virol (2000) 0.96
Novel and specific respiratory syncytial virus inhibitors that target virus fusion. J Med Chem (1998) 0.96
Comparative analysis of RNA tumor virus genomes. Haematol Blood Transfus (1979) 0.96
Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers. Virology (2000) 0.95
An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo. J Virol (1997) 0.95
Single amino acid insertion in loop 4 confers amphotropic murine leukemia virus receptor function upon murine Pit1. J Virol (1998) 0.94
Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants. J Virol (1997) 0.94
Amphotropic murine leukemia virus entry is determined by specific combinations of residues from receptor loops 2 and 4. J Virol (1999) 0.92
E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation. J Biol Chem (1996) 0.92
Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone (2001) 0.92
Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res (1992) 0.91
Prenatal nicotine alters vigilance states and AchR gene expression in the neonatal rat: implications for SIDS. Am J Physiol Regul Integr Comp Physiol (2001) 0.91
Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4. J Virol (2000) 0.90
Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors. Gene (1999) 0.89
CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats. Antiviral Res (1998) 0.89
Mammalian expression-and-transmission vector derived from Akv murine leukemia virus. Gene (1986) 0.89
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol (1994) 0.89
The kissing-loop motif is a preferred site of 5' leader recombination during replication of SL3-3 murine leukemia viruses in mice. J Virol (1999) 0.89
Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses. J Virol (1994) 0.88
Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines. J Virol (1996) 0.88
In vivo gene delivery to articular chondrocytes mediated by an adeno-associated virus vector. J Orthop Res (2004) 0.87
Measurement of hygromycin B phosphotransferase activity in crude mammalian cell extracts by a simple dot-blot assay. Gene (1992) 0.87
Functional screening of a retroviral peptide library for MHC class I presentation. Gene (2001) 0.86
A correlation between dexamethasone inducibility and basal expression levels of retroviral vector proviruses. Nucleic Acids Res (1993) 0.86
Involvement of nuclear factor I-binding sites in control of Akv virus gene expression. J Virol (1990) 0.86
HFE genotype modifies the influence of heme iron intake on iron status. Epidemiology (2005) 0.85
Murine leukemia virus proviral insertions between the N-ras and unr genes in B-cell lymphoma DNA affect the expression of N-ras only. J Virol (2001) 0.85
Exogenous thymidine is preferentially incorporated into human cytomegalovirus DNA in infected human fibroblasts. J Virol (1996) 0.85
Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses. J Virol (1999) 0.84
A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways. Mol Biol Cell (1993) 0.84
Cell volume increase in murine MC3T3-E1 pre-osteoblasts attaching onto biocompatible tantalum observed by magnetic AC mode atomic force microscopy. Eur Cell Mater (2005) 0.83
Pathogenicity of BALB/c-derived N-tropic murine leukemia viruses. Virology (1990) 0.83
A 13-amino-acid Pit1-specific loop 4 sequence confers feline leukemia virus subgroup B receptor function upon Pit2. J Virol (2000) 0.82
Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors. J Virol (1998) 0.82
E-box variants direct formation of distinct complexes with the basic helix-loop-helix protein ALF1. J Mol Biol (1995) 0.81
Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer. J Virol (1999) 0.81
A common multiple cloning site in a set of vectors for expression of eukaryotic genes in mammalian, insect and bacterial cells. Gene (1994) 0.81
Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats. J Virol (1991) 0.81
Comparative analysis of the genomes of feline leukemia viruses. J Virol (1980) 0.81
Efficient replication and expression of murine leukemia virus with major deletions in the enhancer region of U3. Virology (1992) 0.81